Jan Wald
Jan Wald
chance good sure
I don't think it's a sure thing by any stretch, but I think they have a good chance of making it.
attractive certainly definitely
I think they (St. Jude) definitely look like they are in play. They certainly would be an attractive candidate.
easily
I think they easily could go up to $76 without a lot of damage.
company hard indication processes
It is another indication that the processes could have been better ? but the company is working hard on it already.
actions company eventually expenses given remain stay
I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish.
growth jude needs people thinking walk
J&J needs something like Guidant to revitalize its growth. People are now thinking that if J&J does walk away, St. Jude is in their scopes.
needs
J&J needs something like Guidant to revitalize its growth,
actions louder speak
This is one of those times when actions speak louder than words.
certainly company
I certainly think it could be a stand-alone company. I'm not certain it should be.
employees minnesota risk
I don't think there's much risk to employees ? especially the Minnesota contingent.
beginning fourth looked looking quarter
The end of the fourth quarter looked better than the beginning, and 2006 is looking OK.
boston less time worse
The less time they give Boston Scientific, the worse it is for Boston Scientific. They have less time to react.
johnson stronger threat
The combination of Guidant and Johnson & Johnson is a stronger threat to Medtronic,